Company / Assets per Share
Edwards Lifesciences Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$23.59
FY2025
5-year range
$13.62 / $23.59
FY2021-FY2025
Trend
+8.6%
vs FY2024
Sector context
#100 of 158
Health Care
What the data says
At $23.59, Edwards Lifesciences's assets per share ranks #100 of 158 in the Health Care sector. Assets per Share has increased for 5 consecutive years, from $11.59 in FY2020 to $23.59 in FY2025.
Based on SEC 10-K filings.
23.59 in FY2025 with a 5-year CAGR of +15.3%.
Improved from $15.39 to $23.59 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- +20.1%
- 5-Year CAGR
- +15.3%
- 10-Year CAGR
- -
Sector benchmark
#100 of 158 in Health CareTop 63% of 158This company $23.59 Sector average $117.21
▼
-79.9% below sector average
Key checks
Key Insights
- Edwards Lifesciences's assets per share has grown for 5 consecutive years.
- In FY2025, assets per share increased 8.6% year-over-year.
- Ranks #100 out of 158 companies in the Health Care sector.
- Peak assets per share was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score 3.16 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $23.59 | +8.6% |
| FY2024 | $21.72 | +41.1% |
| FY2023 | $15.39 | +12.9% |
| FY2022 | $13.63 | +0.1% |
| FY2021 | $13.62 | +17.5% |
| FY2020 | $11.59 | -62.6% |
| FY2019 | $31.03 | +21.1% |
| FY2018 | $25.63 | -4.3% |
| FY2017 | $26.78 | +25.6% |
| FY2016 | $21.31 | -43.4% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026